RxDoctor Payments Data

Kimberly Bruyere

Nurse Practitioner · Rogers, ARNPI 1881626331

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,061 and has fallen 55.3% since, to $474 in 2025. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,803in general payments, 2019–2025

Across 228 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$788
  • Pfizer$343
  • Novo Nordisk$303
  • Amgen$301
  • Boehringer Ingelheim$281
  • AstraZeneca$268
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$3,803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,803 in reported general payments places this provider in the 90th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas →

Medicare billing

Part B allowed, 2024
$32,376
Medicare patients
287
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate23$348

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Rogers

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →